Pharma Cos. Seek To Toss Blood Pressure Drug Antitrust Suit

Law360, New York (March 13, 2017, 8:38 PM EDT) -- Mylan, Teva Pharmaceuticals and other generic-drug manufacturers on Friday slammed antitrust claims brought by drug buyers in New York federal court over an alleged conspiracy to jack up the price of generic blood pressure medication propranolol, arguing that the buyers haven’t plausibly shown there was a price-fixing conspiracy.

The drugmakers said that the direct purchaser plaintiffs’ consolidated amended complaint, even after weeks of fact-finding efforts, still fail to support their claim that the companies developed a price-fixing scheme around propranolol. The new complaint has charts and graphs...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.